US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

86.49

+2.583.07%

Post-market: 86.490.00000.00%16:49 EST

Volume:137.46K

Turnover:11.80M

Market Cap:1.26B

PE:-8.45

High:88.72

Open:83.40

Low:82.81

Close:83.91

52wk High:94.57

52wk Low:10.81

Shares:14.54M

Float Shares:7.81M

Volume Ratio:0.80

T/O Rate:1.76%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-10.2368

EPS(LYR):112.62

ROE:-144.07%

ROA:-60.97%

PB:34.15

PE(LYR):0.77

Loading ...

Overview Company News Filings

Why Inhibrx's Recent Strength May Not Be Built to Last

Benzinga_recent_news

BRIEF-Inhibrx Biosciences, Inc Provides Progress Updates On The Inbrx-106 Program And The Expansion Cohorts Of The Ozekibart (Inbrx-109) Program

Inhibrx Biosciences Advances INBRX-106 Phase 2/3 Trial for Head and Neck Cancer

Inhibrx Biosciences Provides Progress Updates on the Inbrx-106 Program and the Expansion Cohorts of the Ozekibart (Inbrx-109) Program

THOMSON REUTERS

Inhibrx Biosciences Reports Promising Q3 2025 Results

Inhibrx options imply 7.3% move in share price post-earnings

Inhibrx Biosciences Q3 EPS $(2.28) Misses $(1.72) Estimate, Cash And Cash Equivalents Of $153.1M

Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share

MT Newswires Live

Inhibrx Biosciences posts Q3 net loss of $35.3 million

Inhibrx Q3 Operating Income USD -33.812 Million

THOMSON REUTERS

Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma

TRANSCENTA-B (06628) Partner Inhibrx Reports Positive Phase II Trial Results for Ozekibart in Chondrosarcoma, Plans BLA Submission by 2026

Transcenta Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma

Inhibrx’s Phase 1 Study of INBRX-109: A Potential Game-Changer in Cancer Treatment

US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone

Benzinga_recent_news

Nasdaq Net Change Percentage Gainers & Losers

Top Midday Gainers

MT Newswires Live

Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday?

Benzinga_recent_news

Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday

Why Are Inhibrx Biosciences Shares Soaring 76% After Hours?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INBX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","market":"US","secType":"STK","nameCN":"Inhibrx Biosciences","latestPrice":86.49,"timestamp":1770670800000,"preClose":83.91,"halted":0,"volume":137457,"hourTrading":{"tag":"盘后","latestPrice":86.49,"preClose":86.49,"latestTime":"16:49 EST","volume":1595,"amount":137951.55,"timestamp":1770673772463,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.030747229174115105,"floatShares":7808544,"shares":14543738,"eps":-10.2368,"marketStatus":"Post-Mkt","change":2.58,"latestTime":"02-09 18:00:06 EST","open":83.4,"high":88.72,"low":82.81,"amount":11803975.545149999,"amplitude":0.070433,"askPrice":88.18,"askSize":22,"bidPrice":84.82,"bidSize":23,"shortable":3,"etf":0,"ttmEps":-10.2368,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":83.91,"preHourTrading":{"tag":"盘前","latestPrice":83,"preClose":83.91,"latestTime":"09:13 EST","volume":70,"amount":5752.200019999999,"timestamp":1770646436003,"change":-0.91,"changeRate":-0.010845,"amplitude":0.034442},"postHourTrading":{"tag":"盘后","latestPrice":86.49,"preClose":86.49,"latestTime":"16:49 EST","volume":1595,"amount":137951.55,"timestamp":1770673772463,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.798404,"impliedVol":0.828,"impliedVolPercentile":0.3506},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INBX\",,,,,undefined,":{"symbol":"INBX","floatShares":7808544,"roa":"-60.97%","roe":"-144.07%","lyrEps":112.62,"volumeRatio":0.798404,"shares":14543738,"dividePrice":0,"high":88.72,"amplitude":0.070433,"preClose":83.91,"low":82.81,"week52Low":10.805,"pbRate":"34.15","psRate":"898.49","week52High":94.565,"institutionHeld":0,"latestPrice":86.49,"committee":0.022222,"eps":-10.2368,"divideRate":0,"volume":137457,"delay":0,"ttmEps":-10.2368,"open":83.4,"prevYearClose":79,"prevWeekClose":83.91,"prevMonthClose":76.27,"prevQuarterClose":79,"fiveDayClose":82.23,"twentyDayClose":72.86,"sixtyDayClose":77.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-14","symbol":"INBX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-2.28},{"market":"US","date":"2025-08-13","symbol":"INBX","fiscalQuarterEnding":"2025/06","expectedEps":-2.92,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.85},{"market":"US","date":"2025-05-14","symbol":"INBX","fiscalQuarterEnding":"2025/03","expectedEps":-2.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-2.8},{"market":"US","date":"2025-03-17","symbol":"INBX","fiscalQuarterEnding":"2024/12","expectedEps":-2.88,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":-3.09},{"market":"US","date":"2024-11-14","symbol":"INBX","fiscalQuarterEnding":"2024/09","expectedEps":-3.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-2.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INBX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1723525200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INBX","date":"2026-02-06","current":-8.196897,"percent":0.405053,"low":-22.314917,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"high":0.20643,"avg":-6.983132,"sd":5.387362,"marketCap":1185750959},"quantilePoints":[{"date":"2021-02-12","current":-16.889381,"twenty":-17.941375,"median":-10.074177,"eighty":-8.644167,"marketCap":1262987941},{"date":"2021-02-19","current":-13.480238,"twenty":-17.863711,"median":-10.414026,"eighty":-8.674681,"marketCap":1008052184},{"date":"2021-02-26","current":-12.81959,"twenty":-17.793107,"median":-11.725235,"eighty":-8.696792,"marketCap":958648953},{"date":"2021-03-05","current":-13.308772,"twenty":-17.73259,"median":-12.274934,"eighty":-8.725738,"marketCap":995229972},{"date":"2021-03-12","current":-11.657921,"twenty":-17.668038,"median":-11.894179,"eighty":-8.754622,"marketCap":887447580},{"date":"2021-03-19","current":-10.988496,"twenty":-17.62971,"median":-11.861399,"eighty":-8.783223,"marketCap":836488234},{"date":"2021-03-26","current":-8.955426,"twenty":-17.495564,"median":-11.667839,"eighty":-8.811823,"marketCap":681722811},{"date":"2021-04-01","current":-10.16535,"twenty":-17.392684,"median":-11.384825,"eighty":-8.776319,"marketCap":773827112},{"date":"2021-04-09","current":-10.16535,"twenty":-17.332167,"median":-10.784251,"eighty":-8.806892,"marketCap":773827112},{"date":"2021-04-16","current":-8.940549,"twenty":-17.271649,"median":-10.681055,"eighty":-8.823657,"marketCap":680590381},{"date":"2021-04-23","current":-9.411627,"twenty":-17.246434,"median":-10.552129,"eighty":-8.828588,"marketCap":716450662},{"date":"2021-04-30","current":-10.594488,"twenty":-17.204072,"median":-10.445517,"eighty":-8.843382,"marketCap":806494786},{"date":"2021-05-07","current":-7.842802,"twenty":-17.16877,"median":-10.413285,"eighty":-8.806892,"marketCap":597025442},{"date":"2021-05-14","current":-8.388445,"twenty":-17.077994,"median":-10.267003,"eighty":-8.695106,"marketCap":631817649},{"date":"2021-05-21","current":-8.418565,"twenty":-16.931743,"median":-10.16535,"eighty":-8.624442,"marketCap":634086294},{"date":"2021-05-28","current":-10.622351,"twenty":-16.840967,"median":-10.138395,"eighty":-8.634304,"marketCap":800075491},{"date":"2021-06-04","current":-10.978772,"twenty":-16.758261,"median":-10.16535,"eighty":-8.657626,"marketCap":826921124},{"date":"2021-06-11","current":-12.248836,"twenty":-16.703795,"median":-10.324029,"eighty":-8.693326,"marketCap":922582324},{"date":"2021-06-18","current":-13.338179,"twenty":-16.643278,"median":-10.413656,"eighty":-8.699781,"marketCap":1004631654},{"date":"2021-06-25","current":-12.966698,"twenty":-16.59789,"median":-10.452955,"eighty":-8.708687,"marketCap":976651698},{"date":"2021-07-02","current":-15.562046,"twenty":-16.480889,"median":-10.58834,"eighty":-8.746733,"marketCap":1172133281},{"date":"2021-07-09","current":-14.337162,"twenty":-16.480889,"median":-10.601716,"eighty":-8.762512,"marketCap":1079875048},{"date":"2021-07-16","current":-12.700637,"twenty":-16.369941,"median":-10.760395,"eighty":-8.79703,"marketCap":956612000},{"date":"2021-07-23","current":-14.558043,"twenty":-15.986664,"median":-10.983634,"eighty":-8.821685,"marketCap":1096511779},{"date":"2021-07-30","current":-14.286962,"twenty":-15.764767,"median":-11.079173,"eighty":-8.826616,"marketCap":1076093973},{"date":"2021-08-06","current":-13.73476,"twenty":-15.562046,"median":-11.384825,"eighty":-8.831547,"marketCap":1034502147},{"date":"2021-08-13","current":-13.397679,"twenty":-15.511846,"median":-11.677756,"eighty":-8.861134,"marketCap":1046961596},{"date":"2021-08-20","current":-13.800142,"twenty":-15.336145,"median":-11.861847,"eighty":-8.875927,"marketCap":1078412125},{"date":"2021-08-27","current":-14.469299,"twenty":-15.305844,"median":-11.921916,"eighty":-8.89072,"marketCap":1130703367},{"date":"2021-09-03","current":-15.225737,"twenty":-15.25037,"median":-12.221226,"eighty":-8.940031,"marketCap":1189815205},{"date":"2021-09-10","current":-16.530107,"twenty":-15.521886,"median":-12.271925,"eighty":-8.940445,"marketCap":1291745234},{"date":"2021-09-17","current":-17.950853,"twenty":-15.909368,"median":-12.434577,"eighty":-8.944079,"marketCap":1402769392},{"date":"2021-09-24","current":-17.829629,"twenty":-16.480889,"median":-12.612787,"eighty":-8.953333,"marketCap":1393296341},{"date":"2021-10-01","current":-15.730029,"twenty":-16.490733,"median":-12.663254,"eighty":-8.96336,"marketCap":1229223097},{"date":"2021-10-08","current":-12.97097,"twenty":-16.480889,"median":-12.827884,"eighty":-9.035825,"marketCap":1013616457},{"date":"2021-10-15","current":-19.255223,"twenty":-16.545624,"median":-12.97097,"eighty":-9.054369,"marketCap":1504699420},{"date":"2021-10-22","current":-18.493936,"twenty":-16.728002,"median":-13.052038,"eighty":-9.0546,"marketCap":1445208660},{"date":"2021-10-29","current":-19.487973,"twenty":-16.918658,"median":-13.192599,"eighty":-9.065511,"marketCap":1522887678},{"date":"2021-11-05","current":-21.694251,"twenty":-17.230296,"median":-13.217847,"eighty":-9.068239,"marketCap":1695297206},{"date":"2021-11-12","current":-20.979364,"twenty":-17.376546,"median":-13.248255,"eighty":-9.084018,"marketCap":1641173724},{"date":"2021-11-19","current":-21.018179,"twenty":-17.627693,"median":-13.306251,"eighty":-9.093008,"marketCap":1644210123},{"date":"2021-11-26","current":-18.59711,"twenty":-17.724892,"median":-13.36308,"eighty":-9.09439,"marketCap":1454814728},{"date":"2021-12-03","current":-17.903297,"twenty":-17.836807,"median":-13.397679,"eighty":-9.099442,"marketCap":1400539094},{"date":"2021-12-10","current":-19.009517,"twenty":-17.922319,"median":-13.461918,"eighty":-9.105715,"marketCap":1487076469},{"date":"2021-12-17","current":-21.411178,"twenty":-18.339089,"median":-13.523752,"eighty":-9.141289,"marketCap":1674953664},{"date":"2021-12-23","current":-21.576141,"twenty":-18.404686,"median":-13.538298,"eighty":-9.19146,"marketCap":1687858360},{"date":"2021-12-31","current":-21.187994,"twenty":-18.643832,"median":-13.635278,"eighty":-9.244088,"marketCap":1657494369},{"date":"2022-01-07","current":-16.535077,"twenty":-18.65535,"median":-13.71468,"eighty":-9.282247,"marketCap":1293506025},{"date":"2022-01-14","current":-15.273598,"twenty":-18.643832,"median":-13.796526,"eighty":-9.316764,"marketCap":1194823053},{"date":"2022-01-21","current":-13.614268,"twenty":-18.628162,"median":-13.763835,"eighty":-9.324228,"marketCap":1065016991},{"date":"2022-01-28","current":-11.940383,"twenty":-18.576475,"median":-13.688616,"eighty":-9.34366,"marketCap":934072279},{"date":"2022-02-04","current":-12.561419,"twenty":-18.478419,"median":-13.607802,"eighty":-9.350296,"marketCap":982654665},{"date":"2022-02-11","current":-11.285384,"twenty":-18.41052,"median":-13.552845,"eighty":-9.3572,"marketCap":882833044},{"date":"2022-02-18","current":-10.460571,"twenty":-18.383151,"median":-13.530363,"eighty":-9.371993,"marketCap":818309562},{"date":"2022-02-25","current":-10.741978,"twenty":-18.367013,"median":-13.519646,"eighty":-9.383827,"marketCap":840323456},{"date":"2022-03-04","current":-9.688638,"twenty":-18.346841,"median":-13.443599,"eighty":-9.410447,"marketCap":792220573},{"date":"2022-03-11","current":-10.270911,"twenty":-18.333921,"median":-13.396092,"eighty":-9.411627,"marketCap":839831858},{"date":"2022-03-18","current":-12.055911,"twenty":-18.155202,"median":-13.338179,"eighty":-9.438069,"marketCap":985787767},{"date":"2022-03-25","current":-10.30432,"twenty":-18.141037,"median":-13.280794,"eighty":-9.467655,"marketCap":842563653},{"date":"2022-04-01","current":-11.182502,"twenty":-18.091473,"median":-13.235825,"eighty":-9.492956,"marketCap":914370838},{"date":"2022-04-08","current":-10.084775,"twenty":-18.029445,"median":-13.217847,"eighty":-9.550229,"marketCap":824611857},{"date":"2022-04-14","current":-8.743823,"twenty":-17.966571,"median":-13.19269,"eighty":-9.432781,"marketCap":714964912},{"date":"2022-04-22","current":-7.813121,"twenty":-17.912808,"median":-13.077138,"eighty":-9.380868,"marketCap":638863297},{"date":"2022-04-29","current":-7.564934,"twenty":-17.890994,"median":-13.002219,"eighty":-9.337742,"marketCap":618569533},{"date":"2022-05-06","current":-7.426522,"twenty":-17.855642,"median":-12.966698,"eighty":-9.255063,"marketCap":607251857},{"date":"2022-05-13","current":-7.055067,"twenty":-17.833218,"median":-12.861335,"eighty":-9.106701,"marketCap":661292590},{"date":"2022-05-20","current":-5.626562,"twenty":-17.771363,"median":-12.813715,"eighty":-9.084018,"marketCap":527394503},{"date":"2022-05-27","current":-5.684868,"twenty":-17.745237,"median":-12.660732,"eighty":-9.054369,"marketCap":532859731},{"date":"2022-06-03","current":-4.801943,"twenty":-17.737028,"median":-12.627593,"eighty":-8.95124,"marketCap":450100564},{"date":"2022-06-10","current":-4.089773,"twenty":-17.730073,"median":-12.561419,"eighty":-8.884803,"marketCap":383346708},{"date":"2022-06-17","current":-3.781583,"twenty":-17.724892,"median":-12.459267,"eighty":-8.824644,"marketCap":354459074},{"date":"2022-06-24","current":-4.881073,"twenty":-17.720352,"median":-12.408239,"eighty":-8.7684,"marketCap":457517659},{"date":"2022-07-01","current":-4.822767,"twenty":-17.684176,"median":-12.274934,"eighty":-8.715717,"marketCap":452052431},{"date":"2022-07-08","current":-7.17168,"twenty":-17.633745,"median":-12.248836,"eighty":-8.692608,"marketCap":672223046},{"date":"2022-07-15","current":-7.196668,"twenty":-17.617007,"median":-12.144125,"eighty":-8.612608,"marketCap":674565287},{"date":"2022-07-22","current":-8.458584,"twenty":-17.576513,"median":-12.055911,"eighty":-8.581377,"marketCap":792848436},{"date":"2022-07-29","current":-7.221656,"twenty":-17.524355,"median":-11.894179,"eighty":-8.56331,"marketCap":676907527},{"date":"2022-08-05","current":-9.512263,"twenty":-17.400753,"median":-11.861399,"eighty":-8.555407,"marketCap":891612914},{"date":"2022-08-12","current":-8.625805,"twenty":-17.350322,"median":-11.769735,"eighty":-8.539628,"marketCap":955350999},{"date":"2022-08-19","current":-6.788501,"twenty":-17.27656,"median":-11.657921,"eighty":-8.520336,"marketCap":751860455},{"date":"2022-08-26","current":-6.933087,"twenty":-17.270113,"median":-11.575505,"eighty":-8.459312,"marketCap":767874106},{"date":"2022-09-02","current":-5.698815,"twenty":-17.254503,"median":-11.411593,"eighty":-8.433116,"marketCap":631172205},{"date":"2022-09-09","current":-5.543649,"twenty":-17.222227,"median":-11.316139,"eighty":-8.402544,"marketCap":613986823},{"date":"2022-09-16","current":-5.099311,"twenty":-17.176839,"median":-11.219387,"eighty":-8.38282,"marketCap":564774139},{"date":"2022-09-23","current":-5.205105,"twenty":-17.156666,"median":-11.106139,"eighty":-8.343685,"marketCap":576491445},{"date":"2022-09-30","current":-6.330057,"twenty":-16.959985,"median":-11.073112,"eighty":-8.269405,"marketCap":701085463},{"date":"2022-10-07","current":-10.755807,"twenty":-16.908326,"median":-11.043041,"eighty":-8.269405,"marketCap":1191259423},{"date":"2022-10-14","current":-10.526585,"twenty":-16.889381,"median":-10.983634,"eighty":-8.297841,"marketCap":1165871927},{"date":"2022-10-21","current":-10.932132,"twenty":-16.806498,"median":-10.958184,"eighty":-8.303923,"marketCap":1210788266},{"date":"2022-10-28","current":-11.542215,"twenty":-16.768347,"median":-10.953974,"eighty":-8.322526,"marketCap":1278358062},{"date":"2022-11-04","current":-10.914499,"twenty":-16.717916,"median":-10.967397,"eighty":-8.343685,"marketCap":1208835381},{"date":"2022-11-11","current":-11.344191,"twenty":-16.647312,"median":-10.962791,"eighty":-8.354397,"marketCap":1423695985},{"date":"2022-11-18","current":-10.049794,"twenty":-16.62714,"median":-10.967397,"eighty":-8.354465,"marketCap":1261249181},{"date":"2022-11-25","current":-10.525216,"twenty":-16.611581,"median":-10.949764,"eighty":-8.365585,"marketCap":1320914629},{"date":"2022-12-02","current":-11.278257,"twenty":-16.580652,"median":-10.937999,"eighty":-8.379929,"marketCap":1415421215},{"date":"2022-12-09","current":-9.435563,"twenty":-16.54284,"median":-10.900911,"eighty":-8.38732,"marketCap":1184163164},{"date":"2022-12-16","current":-9.373099,"twenty":-16.531101,"median":-10.878658,"eighty":-8.393763,"marketCap":1176323908},{"date":"2022-12-23","current":-8.609648,"twenty":-16.490733,"median":-10.784251,"eighty":-8.401054,"marketCap":1080510779},{"date":"2022-12-30","current":-8.550654,"twenty":-16.480889,"median":-10.755807,"eighty":-8.386195,"marketCap":1073107038},{"date":"2023-01-06","current":-8.026649,"twenty":-16.471483,"median":-10.69346,"eighty":-8.360025,"marketCap":1007344390},{"date":"2023-01-13","current":-8.210571,"twenty":-16.426351,"median":-10.672935,"eighty":-8.338773,"marketCap":1030426644},{"date":"2023-01-20","current":-8.391023,"twenty":-16.377843,"median":-10.653608,"eighty":-8.307919,"marketCap":1053073383},{"date":"2023-01-27","current":-9.418212,"twenty":-16.362213,"median":-10.622351,"eighty":-8.325121,"marketCap":1181985593},{"date":"2023-02-03","current":-8.953201,"twenty":-16.33033,"median":-10.598102,"eighty":-8.337136,"marketCap":1123626687},{"date":"2023-02-10","current":-8.016238,"twenty":-16.291538,"median":-10.582191,"eighty":-8.307919,"marketCap":1006037848},{"date":"2023-02-17","current":-8.311208,"twenty":-16.132459,"median":-10.5517,"eighty":-8.275092,"marketCap":1043056556},{"date":"2023-02-24","current":-8.030119,"twenty":-16.054745,"median":-10.525901,"eighty":-8.231392,"marketCap":1007779905},{"date":"2023-03-03","current":-8.387553,"twenty":-15.986664,"median":-10.497454,"eighty":-8.231392,"marketCap":1052637869},{"date":"2023-03-10","current":-6.435629,"twenty":-15.890044,"median":-10.456763,"eighty":-8.19669,"marketCap":934620687},{"date":"2023-03-17","current":-6.270613,"twenty":-15.797914,"median":-10.414026,"eighty":-8.099523,"marketCap":910656054},{"date":"2023-03-24","current":-5.790566,"twenty":-15.764767,"median":-10.407228,"eighty":-8.067817,"marketCap":840940758},{"date":"2023-03-31","current":-5.661554,"twenty":-15.730029,"median":-10.399775,"eighty":-8.033589,"marketCap":822204772},{"date":"2023-04-06","current":-5.208509,"twenty":-15.644351,"median":-10.35682,"eighty":-8.023608,"marketCap":756410961},{"date":"2023-04-14","current":-5.499418,"twenty":-15.574223,"median":-10.30432,"eighty":-7.994722,"marketCap":798658421},{"date":"2023-04-21","current":-5.892662,"twenty":-15.521886,"median":-10.270911,"eighty":-7.963641,"marketCap":855767729},{"date":"2023-04-28","current":-6.192849,"twenty":-15.371285,"median":-10.226889,"eighty":-7.840005,"marketCap":899362621},{"date":"2023-05-05","current":-8.07802,"twenty":-15.311904,"median":-10.209425,"eighty":-7.808348,"marketCap":1173138543},{"date":"2023-05-12","current":-6.709665,"twenty":-15.280047,"median":-10.16535,"eighty":-7.729148,"marketCap":1092923942},{"date":"2023-05-19","current":-6.50133,"twenty":-15.255016,"median":-10.150431,"eighty":-7.546255,"marketCap":1058988661},{"date":"2023-05-26","current":-6.166624,"twenty":-15.230664,"median":-10.123541,"eighty":-7.399027,"marketCap":1004469064},{"date":"2023-06-02","current":-6.482587,"twenty":-15.150093,"median":-10.101438,"eighty":-7.301546,"marketCap":1055935564},{"date":"2023-06-09","current":-6.578982,"twenty":-15.099664,"median":-10.081052,"eighty":-7.190357,"marketCap":1071637208},{"date":"2023-06-16","current":-7.449218,"twenty":-15.081916,"median":-10.06194,"eighty":-7.181675,"marketCap":1213388161},{"date":"2023-06-23","current":-7.130577,"twenty":-15.043354,"median":-10.049658,"eighty":-7.147018,"marketCap":1161485505},{"date":"2023-06-30","current":-6.889589,"twenty":-14.978471,"median":-10.010787,"eighty":-7.109449,"marketCap":1122231394},{"date":"2023-07-07","current":-6.694121,"twenty":-14.879324,"median":-10.003176,"eighty":-7.080055,"marketCap":1090391950},{"date":"2023-07-14","current":-6.71822,"twenty":-14.813575,"median":-9.929589,"eighty":-7.055067,"marketCap":1094317361},{"date":"2023-07-21","current":-6.734286,"twenty":-14.720843,"median":-9.757019,"eighty":-7.020794,"marketCap":1096934301},{"date":"2023-07-28","current":-5.612351,"twenty":-14.603223,"median":-9.723592,"eighty":-6.959208,"marketCap":914184610},{"date":"2023-08-04","current":-5.398139,"twenty":-14.56955,"median":-9.684017,"eighty":-6.913688,"marketCap":879292068},{"date":"2023-08-11","current":-4.03189,"twenty":-14.558043,"median":-9.636138,"eighty":-6.825667,"marketCap":694323632},{"date":"2023-08-18","current":-4.184036,"twenty":-14.524162,"median":-9.629385,"eighty":-6.795871,"marketCap":720524524},{"date":"2023-08-25","current":-4.754587,"twenty":-14.503242,"median":-9.590932,"eighty":-6.760289,"marketCap":818777868},{"date":"2023-09-01","current":-5.426568,"twenty":-14.469299,"median":-9.50261,"eighty":-6.734286,"marketCap":934498474},{"date":"2023-09-08","current":-5.464605,"twenty":-14.447925,"median":-9.46202,"eighty":-6.706556,"marketCap":941048697},{"date":"2023-09-15","current":-5.071559,"twenty":-14.422502,"median":-9.438069,"eighty":-6.644838,"marketCap":873363060},{"date":"2023-09-22","current":-4.949842,"twenty":-14.389111,"median":-9.414919,"eighty":-6.609239,"marketCap":852402346},{"date":"2023-09-29","current":-4.617655,"twenty":-14.346133,"median":-9.407047,"eighty":-6.577375,"marketCap":795197066},{"date":"2023-10-06","current":-4.749515,"twenty":-14.31098,"median":-9.378463,"eighty":-6.507756,"marketCap":817904505},{"date":"2023-10-13","current":-4.513688,"twenty":-14.290456,"median":-9.369034,"eighty":-6.480396,"marketCap":777293123},{"date":"2023-10-20","current":-4.009068,"twenty":-14.254834,"median":-9.345778,"eighty":-6.435381,"marketCap":690393498},{"date":"2023-10-27","current":-3.867064,"twenty":-14.245721,"median":-9.330985,"eighty":-6.382845,"marketCap":665939333},{"date":"2023-11-03","current":-4.062319,"twenty":-14.23073,"median":-9.300224,"eighty":-6.304458,"marketCap":699563811},{"date":"2023-11-10","current":-4.235537,"twenty":-14.186119,"median":-9.266506,"eighty":-6.270701,"marketCap":799127199},{"date":"2023-11-17","current":-5.26616,"twenty":-14.175985,"median":-9.233113,"eighty":-6.246101,"marketCap":993576892},{"date":"2023-11-24","current":-5.148354,"twenty":-14.166482,"median":-9.221106,"eighty":-6.167838,"marketCap":971350279},{"date":"2023-12-01","current":-5.206004,"twenty":-14.131341,"median":-9.105221,"eighty":-6.111798,"marketCap":982227132},{"date":"2023-12-08","current":-6.356488,"twenty":-14.04259,"median":-9.094269,"eighty":-6.096789,"marketCap":1199291289},{"date":"2023-12-15","current":-6.902905,"twenty":-14.028044,"median":-9.068239,"eighty":-6.096789,"marketCap":1302384941},{"date":"2023-12-22","current":-7.489427,"twenty":-14.025921,"median":-9.0546,"eighty":-6.100835,"marketCap":1413045100},{"date":"2023-12-29","current":-8.757716,"twenty":-14.008907,"median":-9.009394,"eighty":-6.107413,"marketCap":1652335870},{"date":"2024-01-05","current":-9.281575,"twenty":-13.987173,"median":-9.0546,"eighty":-6.120086,"marketCap":1751173361},{"date":"2024-01-12","current":-9.274056,"twenty":-13.943671,"median":-9.061419,"eighty":-6.154509,"marketCap":1749754642},{"date":"2024-01-19","current":-8.211299,"twenty":-13.935913,"median":-9.054023,"eighty":-6.159602,"marketCap":1549242218},{"date":"2024-01-26","current":-9.416751,"twenty":-13.905441,"median":-9.0546,"eighty":-6.166624,"marketCap":1776677287},{"date":"2024-02-02","current":-9.534775,"twenty":-13.893773,"median":-9.068239,"eighty":-6.167838,"marketCap":1798944976},{"date":"2024-02-09","current":-9.356484,"twenty":-13.878644,"median":-9.094269,"eighty":-6.192849,"marketCap":1765306552},{"date":"2024-02-16","current":-9.539797,"twenty":-13.835161,"median":-9.100679,"eighty":-6.225609,"marketCap":1799892537},{"date":"2024-02-23","current":-9.625175,"twenty":-13.830421,"median":-9.105273,"eighty":-6.230052,"marketCap":1816001078},{"date":"2024-03-01","current":-7.192485,"twenty":-13.817912,"median":-9.107687,"eighty":-6.241337,"marketCap":1735985333},{"date":"2024-03-08","current":-7.02362,"twenty":-13.807049,"median":-9.100679,"eighty":-6.252765,"marketCap":1695227829},{"date":"2024-03-15","current":-6.870463,"twenty":-13.801122,"median":-9.094269,"eighty":-6.255798,"marketCap":1658261720},{"date":"2024-03-22","current":-6.866535,"twenty":-13.794357,"median":-9.068239,"eighty":-6.258187,"marketCap":1657313871},{"date":"2024-03-28","current":-6.901879,"twenty":-13.75802,"median":-9.0546,"eighty":-6.261305,"marketCap":1665844512},{"date":"2024-04-05","current":-6.803702,"twenty":-13.722712,"median":-8.965343,"eighty":-6.267575,"marketCap":1642148288},{"date":"2024-04-12","current":-6.876353,"twenty":-13.699042,"median":-8.949082,"eighty":-6.270876,"marketCap":1659683493},{"date":"2024-04-19","current":-6.764431,"twenty":-13.676978,"median":-8.940031,"eighty":-6.285296,"marketCap":1632669799},{"date":"2024-04-26","current":-6.693743,"twenty":-13.636249,"median":-8.888993,"eighty":-6.295007,"marketCap":1615608518},{"date":"2024-05-03","current":-6.678035,"twenty":-13.606508,"median":-8.861134,"eighty":-6.300411,"marketCap":1611817122},{"date":"2024-05-10","current":-6.811556,"twenty":-13.591628,"median":-8.831645,"eighty":-6.305537,"marketCap":1644043986},{"date":"2024-05-17","current":-6.66535,"twenty":-13.56577,"median":-8.821685,"eighty":-6.320681,"marketCap":1807342945},{"date":"2024-05-24","current":-6.607374,"twenty":-13.544117,"median":-8.774994,"eighty":-6.333212,"marketCap":1791622362},{"date":"2024-05-31","current":-6.591913,"twenty":-13.536996,"median":-8.765808,"eighty":-6.33955,"marketCap":1787430207},{"date":"2024-06-07","current":-1.428017,"twenty":-13.534391,"median":-8.762512,"eighty":-6.320681,"marketCap":235088680},{"date":"2024-06-14","current":-1.458793,"twenty":-13.530648,"median":-8.74769,"eighty":-6.294936,"marketCap":240155247},{"date":"2024-06-21","current":-1.274136,"twenty":-13.527902,"median":-8.742788,"eighty":-6.264538,"marketCap":209755848},{"date":"2024-06-28","current":-1.236325,"twenty":-13.525827,"median":-8.73905,"eighty":-6.257641,"marketCap":203531210},{"date":"2024-07-05","current":-1.181807,"twenty":-13.520467,"median":-8.720695,"eighty":-6.23625,"marketCap":194556149},{"date":"2024-07-12","current":-1.1651,"twenty":-13.501419,"median":-8.701753,"eighty":-6.16711,"marketCap":191805728},{"date":"2024-07-15","current":-1.168617,"twenty":-13.494359,"median":-8.700162,"eighty":-6.163815,"marketCap":192384764},{"date":"2024-08-02","current":-1.28117,"twenty":-13.487298,"median":-8.699924,"eighty":-6.158329,"marketCap":210913921},{"date":"2024-08-09","current":-1.005943,"twenty":-13.450927,"median":-8.696095,"eighty":-6.09615,"marketCap":165604341},{"date":"2024-08-16","current":0.104301,"twenty":-13.431551,"median":-8.6648,"eighty":-6.071261,"marketCap":179428830},{"date":"2024-08-23","current":0.109307,"twenty":-13.403851,"median":-8.63741,"eighty":-5.995926,"marketCap":188041992},{"date":"2024-08-30","current":0.117049,"twenty":-13.39514,"median":-8.624442,"eighty":-5.904035,"marketCap":201359824},{"date":"2024-09-06","current":0.134972,"twenty":-13.390591,"median":-8.609648,"eighty":-5.798831,"marketCap":232193500},{"date":"2024-09-13","current":0.126894,"twenty":-13.3581,"median":-8.599787,"eighty":-5.718185,"marketCap":218296632},{"date":"2024-09-20","current":0.147174,"twenty":-13.320535,"median":-8.57594,"eighty":-5.693236,"marketCap":253183560},{"date":"2024-09-27","current":0.128998,"twenty":-13.305746,"median":-8.560338,"eighty":-5.649553,"marketCap":221915608},{"date":"2024-10-04","current":0.125211,"twenty":-13.276207,"median":-8.555407,"eighty":-5.607263,"marketCap":215401451},{"date":"2024-10-11","current":0.131102,"twenty":-13.252097,"median":-8.535683,"eighty":-5.58388,"marketCap":225534584},{"date":"2024-10-18","current":0.136066,"twenty":-13.240797,"median":-8.522393,"eighty":-5.549996,"marketCap":234075367},{"date":"2024-10-25","current":0.129334,"twenty":-13.231179,"median":-8.49513,"eighty":-5.503238,"marketCap":222494644},{"date":"2024-10-31","current":0.137076,"twenty":-13.224048,"median":-8.462226,"eighty":-5.484857,"marketCap":235812476},{"date":"2024-11-08","current":0.136824,"twenty":-13.217877,"median":-8.459506,"eighty":-5.448787,"marketCap":235378199},{"date":"2024-11-15","current":0.12003,"twenty":-13.207731,"median":-8.443665,"eighty":-5.380467,"marketCap":207439704},{"date":"2024-11-22","current":0.117098,"twenty":-13.192708,"median":-8.434596,"eighty":-5.31642,"marketCap":202373137},{"date":"2024-11-29","current":0.12782,"twenty":-13.171515,"median":-8.426987,"eighty":-5.264154,"marketCap":220902295},{"date":"2024-12-06","current":0.12648,"twenty":-13.08517,"median":-8.411844,"eighty":-5.216231,"marketCap":218586150},{"date":"2024-12-13","current":0.123548,"twenty":-13.067098,"median":-8.398818,"eighty":-5.199699,"marketCap":213519584},{"date":"2024-12-20","current":0.116261,"twenty":-13.024078,"median":-8.388445,"eighty":-5.177816,"marketCap":200925547},{"date":"2024-12-27","current":0.12514,"twenty":-13.01264,"median":-8.38282,"eighty":-5.148354,"marketCap":216270005},{"date":"2025-01-03","current":0.127736,"twenty":-12.995966,"median":-8.368365,"eighty":-5.142063,"marketCap":220757536},{"date":"2025-01-10","current":0.125475,"twenty":-12.979301,"median":-8.354397,"eighty":-5.097874,"marketCap":216849041},{"date":"2025-01-17","current":0.113413,"twenty":-12.968407,"median":-8.346533,"eighty":-5.070194,"marketCap":196003740},{"date":"2025-01-24","current":0.109644,"twenty":-12.940438,"median":-8.330294,"eighty":-5.039101,"marketCap":189489583},{"date":"2025-01-31","current":0.113497,"twenty":-12.895226,"median":-8.311208,"eighty":-4.971878,"marketCap":196148499},{"date":"2025-02-07","current":0.108471,"twenty":-12.866366,"median":-8.300882,"eighty":-4.937061,"marketCap":187462956},{"date":"2025-02-14","current":0.110063,"twenty":-12.829543,"median":-8.262624,"eighty":-4.888294,"marketCap":190213378},{"date":"2025-02-21","current":0.107215,"twenty":-12.818415,"median":-8.231392,"eighty":-4.86555,"marketCap":185291571},{"date":"2025-02-28","current":0.105539,"twenty":-12.791099,"median":-8.210935,"eighty":-4.812772,"marketCap":182396390},{"date":"2025-03-07","current":0.11157,"twenty":-12.69316,"median":-8.180554,"eighty":-4.789981,"marketCap":192819041},{"date":"2025-03-14","current":0.118522,"twenty":-12.662245,"median":-8.128541,"eighty":-4.744813,"marketCap":204834041},{"date":"2025-03-21","current":0.120949,"twenty":-12.654648,"median":-8.099523,"eighty":-4.702077,"marketCap":204110246},{"date":"2025-03-28","current":0.122836,"twenty":-12.635275,"median":-8.082172,"eighty":-4.65634,"marketCap":207294945},{"date":"2025-04-04","current":0.114344,"twenty":-12.608867,"median":-8.067817,"eighty":-4.615626,"marketCap":192963800},{"date":"2025-04-11","current":0.097102,"twenty":-12.580425,"median":-8.059594,"eighty":-4.551429,"marketCap":163867233},{"date":"2025-04-17","current":0.098389,"twenty":-12.561419,"median":-8.031854,"eighty":-4.48833,"marketCap":166038618},{"date":"2025-04-25","current":0.102764,"twenty":-12.551715,"median":-8.025451,"eighty":-4.412256,"marketCap":173421329},{"date":"2025-05-02","current":0.10568,"twenty":-12.478937,"median":-8.000315,"eighty":-4.235537,"marketCap":178343137},{"date":"2025-05-09","current":0.096588,"twenty":-12.439597,"median":-7.991946,"eighty":-4.089773,"marketCap":162998679},{"date":"2025-05-16","current":0.100989,"twenty":-12.434577,"median":-7.97539,"eighty":-4.044568,"marketCap":174000366},{"date":"2025-05-23","current":0.105357,"twenty":-12.381901,"median":-7.908838,"eighty":-3.993853,"marketCap":181527836},{"date":"2025-05-30","current":0.115524,"twenty":-12.32239,"median":-7.842802,"eighty":-3.849968,"marketCap":199043680},{"date":"2025-06-06","current":0.108298,"twenty":-12.28145,"median":-7.820969,"eighty":-3.684995,"marketCap":186594402},{"date":"2025-06-13","current":0.120397,"twenty":-12.27012,"median":-7.741529,"eighty":-1.480952,"marketCap":207439704},{"date":"2025-06-20","current":0.12779,"twenty":-12.256868,"median":-7.679625,"eighty":-1.456331,"marketCap":220178499},{"date":"2025-06-27","current":0.124261,"twenty":-12.215704,"median":-7.603614,"eighty":-1.340788,"marketCap":214098620},{"date":"2025-07-03","current":0.1372,"twenty":-12.181568,"median":-7.503213,"eighty":-1.260418,"marketCap":236391512},{"date":"2025-07-11","current":0.176268,"twenty":-12.147999,"median":-7.450386,"eighty":-1.219442,"marketCap":303704465},{"date":"2025-07-18","current":0.198448,"twenty":-12.097216,"median":-7.41608,"eighty":-1.173893,"marketCap":341920852},{"date":"2025-07-25","current":0.193827,"twenty":-12.055911,"median":-7.368888,"eighty":-1.136258,"marketCap":333959105},{"date":"2025-08-01","current":0.184165,"twenty":-12.0097,"median":-7.300695,"eighty":-1.006646,"marketCap":317311815},{"date":"2025-08-08","current":0.179293,"twenty":-11.932996,"median":-7.27517,"eighty":0.093431,"marketCap":308915791},{"date":"2025-08-15","current":-2.118471,"twenty":-11.899726,"median":-7.210926,"eighty":0.095163,"marketCap":346780978},{"date":"2025-08-22","current":-2.137939,"twenty":-11.899726,"median":-7.188912,"eighty":0.095163,"marketCap":349967771},{"date":"2025-08-29","current":-2.467125,"twenty":-11.899726,"median":-7.117001,"eighty":0.095163,"marketCap":403853537},{"date":"2025-09-05","current":-2.452966,"twenty":-11.910821,"median":-7.080055,"eighty":0.095189,"marketCap":401535870},{"date":"2025-09-12","current":-2.517565,"twenty":-11.899726,"median":-7.052928,"eighty":0.095163,"marketCap":412110227},{"date":"2025-09-19","current":-2.358281,"twenty":-11.899726,"median":-7.022207,"eighty":0.095163,"marketCap":386036469},{"date":"2025-09-26","current":-2.817991,"twenty":-11.899726,"median":-6.994363,"eighty":0.095163,"marketCap":461288231},{"date":"2025-10-03","current":-3.102932,"twenty":-11.899726,"median":-6.957161,"eighty":0.095163,"marketCap":507931287},{"date":"2025-10-10","current":-3.09718,"twenty":-11.899726,"median":-6.916619,"eighty":0.095163,"marketCap":506989735},{"date":"2025-10-17","current":-3.238323,"twenty":-11.899726,"median":-6.888862,"eighty":0.095163,"marketCap":530093981},{"date":"2025-10-24","current":-2.5096,"twenty":-11.899726,"median":-6.871444,"eighty":0.095163,"marketCap":410806539},{"date":"2025-10-31","current":-6.947417,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1137250402},{"date":"2025-11-07","current":-7.166874,"twenty":-11.899726,"median":-6.866535,"eighty":0.095163,"marketCap":1173174246},{"date":"2025-11-14","current":-6.603187,"twenty":-11.899726,"median":-6.865553,"eighty":0.095163,"marketCap":1080902115},{"date":"2025-11-21","current":-7.487278,"twenty":-11.861937,"median":-6.865553,"eighty":0.095163,"marketCap":1161172041},{"date":"2025-11-28","current":-7.88865,"twenty":-11.742377,"median":-6.865553,"eighty":0.095163,"marketCap":1223419240},{"date":"2025-12-05","current":-8.197182,"twenty":-11.617777,"median":-6.865553,"eighty":0.095163,"marketCap":1271268138},{"date":"2025-12-12","current":-7.709533,"twenty":-11.403957,"median":-6.865553,"eighty":0.095163,"marketCap":1195640700},{"date":"2025-12-19","current":-8.001185,"twenty":-11.337354,"median":-6.865553,"eighty":0.095163,"marketCap":1240871726},{"date":"2025-12-26","current":-7.536043,"twenty":-11.289254,"median":-6.865553,"eighty":0.095163,"marketCap":1168734785},{"date":"2026-01-02","current":-7.408504,"twenty":-11.181733,"median":-6.865553,"eighty":0.095163,"marketCap":1148955302},{"date":"2026-01-09","current":-7.052146,"twenty":-11.074324,"median":-6.865553,"eighty":0.095163,"marketCap":1093689097},{"date":"2026-01-16","current":-6.733299,"twenty":-10.974222,"median":-6.860645,"eighty":0.095163,"marketCap":1044240388},{"date":"2026-01-23","current":-7.454456,"twenty":-10.939172,"median":-6.859408,"eighty":0.095163,"marketCap":1156081733},{"date":"2026-01-30","current":-6.804571,"twenty":-10.880889,"median":-6.848864,"eighty":0.095163,"marketCap":1055293629},{"date":"2026-02-06","current":-7.645764,"twenty":-10.722571,"median":-6.848864,"eighty":0.095163,"marketCap":1185750959}],"updateTime":1770638527224},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INBX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593747477","title":"Why Inhibrx's Recent Strength May Not Be Built to Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2593747477","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593747477?lang=en_us&edition=fundamental","pubTime":"2025-12-24 20:34","pubTimestamp":1766579640,"startTime":"0","endTime":"0","summary":"An analysis of Inhibrx's sharp rally after trial results, highlighting a timing mismatch in the cycle and risks investors should watch.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/24/INBX-Stock.png?optimize=medium&dpr=2&auto=webp&width=120","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/24/INBX-Stock.png?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/Opinion/25/12/49580838/why-inhibrxs-recent-strength-may-not-be-built-to-last","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/Opinion/25/12/49580838/why-inhibrxs-recent-strength-may-not-be-built-to-last","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2592958643","title":"BRIEF-Inhibrx Biosciences, Inc Provides Progress Updates On The Inbrx-106 Program And The Expansion Cohorts Of The Ozekibart (Inbrx-109) Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2592958643","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592958643?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:11","pubTimestamp":1765923075,"startTime":"0","endTime":"0","summary":"BRIEF-Inhibrx Biosciences, Inc Provides Progress Updates On The Inbrx-106 Program And The Expansion Cohorts Of The Ozekibart (Inbrx-109) ProgramDec 16 (Reuters) - Inhibrx Biosciences Inc INBX.O:INHIBR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA3N5TYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2592958821","title":"Inhibrx Biosciences Advances INBRX-106 Phase 2/3 Trial for Head and Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2592958821","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592958821?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:00","pubTimestamp":1765922423,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc. has announced progress updates on its ongoing clinical programs. The company is currently conducting a randomized Phase 2/3 clinical trial of INBRX-106 in combination with Keytruda  as a first-line treatment for patients with unresectable or metastatic head and neck squamous cell carcinoma . As of the latest update, 46 out of a planned 60 patients have been enrolled in the Phase 2 portion, with full enrollment expected in the first quarter of 2026. The primary endpoint is overall response rate, with secondary endpoints including duration of response, progression free survival, and safety. Additionally, Inhibrx has completed enrollment of a Phase 1/2 trial involving 34 patients with checkpoint inhibitor refractory or relapsed non-small cell lung cancer , also in combination with Keytruda. Primary endpoints for this cohort are objective response rate, disease control rate, duration of response, and safety. Currently, the datasets for both HNSCC and NSCLC lack suf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL3W3R3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2592300799","title":"Inhibrx Biosciences Provides Progress Updates on the Inbrx-106 Program and the Expansion Cohorts of the Ozekibart (Inbrx-109) Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2592300799","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592300799?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:00","pubTimestamp":1765922400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nTUA3N5TYP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBX","BK4139"],"gpt_icon":0},{"id":"2586270443","title":"Inhibrx Biosciences Reports Promising Q3 2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2586270443","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586270443?lang=en_us&edition=fundamental","pubTime":"2025-11-25 11:57","pubTimestamp":1764043023,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences, Inc. ( ($INBX) ) has released its Q3 earnings. Here is a breakdown of the information Inhibrx Biosciences, Inc. presented to i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-promising-q3-2025-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrx-biosciences-reports-promising-q3-2025-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2583868982","title":"Inhibrx options imply 7.3% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2583868982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583868982?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:05","pubTimestamp":1763147115,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Inhibrx (INBX) is normal with calls leading puts 4:1. Implied volatility suggests the market is anticipating a move ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inhibrx-options-imply-7-3-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inhibrx-options-imply-7-3-move-in-share-price-post-earnings-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBX"],"gpt_icon":0},{"id":"2583577452","title":"Inhibrx Biosciences Q3 EPS $(2.28) Misses $(1.72) Estimate, Cash And Cash Equivalents Of $153.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2583577452","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583577452?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:04","pubTimestamp":1763118279,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Q3 EPS $(2.28) Misses $(1.72) Estimate, Cash And Cash Equivalents Of $153.1M","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48859300/inhibrx-biosciences-q3-eps-2-28-misses-1-72-estimate-cash-and-cash-equivalents-of-153-1m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBX"],"gpt_icon":0},{"id":"2583110577","title":"Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2583110577","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583110577?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:03","pubTimestamp":1763118211,"startTime":"0","endTime":"0","summary":"Earnings Flash (INBX) Inhibrx Biosciences Posts Q3 Loss $2.28 a Share","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["INBX"],"gpt_icon":0},{"id":"2583357796","title":"Inhibrx Biosciences posts Q3 net loss of $35.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583357796","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583357796?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:00","pubTimestamp":1763118047,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences Inc. reported a net loss of $35.3 million, or $2.28 per share, basic and diluted, for the third quarter of 2025, compared to a net loss of $43.9 million, or $2.84 per share, for the same period in 2024. Research and development expenses were $28.5 million, down from $38.9 million in the third quarter of 2024, primarily due to decreased process development, manufacturing activities, and lower personnel-related expenses. Cash and cash equivalents totaled $153.1 million as of September 30, 2025, compared to $186.6 million as of June 30, 2025. Other expense was $1.4 million, versus other income of $2.9 million in the same period last year, mainly due to interest expense on outstanding debt. During the period, Inhibrx announced positive topline results from its registrational trial of ozekibart  in chondrosarcoma and interim data from expansion cohorts in colorectal cancer and Ewing sarcoma. The company plans to submit a biologics license application for ozekibart to the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL55wFF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2583187577","title":"Inhibrx Q3 Operating Income USD -33.812 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583187577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583187577?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:00","pubTimestamp":1763118001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nPLX243D5D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2579104428","title":"Transcenta’s Partner Inhibrx Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2579104428","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579104428?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:12","pubTimestamp":1761865932,"startTime":"0","endTime":"0","summary":"An announcement from Transcenta Holding Limited ( ($HK:6628) ) is now available. Transcenta Holding Limited announced that its partner, Inhibrx Bio...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcentas-partner-inhibrx-reports-positive-phase-2-results-for-ozekibart-in-chondrosarcoma?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcentas-partner-inhibrx-reports-positive-phase-2-results-for-ozekibart-in-chondrosarcoma?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"1180750860","title":"TRANSCENTA-B (06628) Partner Inhibrx Reports Positive Phase II Trial Results for Ozekibart in Chondrosarcoma, Plans BLA Submission by 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1180750860","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180750860?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:00","pubTimestamp":1761865216,"startTime":"0","endTime":"0","summary":"TRANSCENTA-B (06628) announced that its partner, Inhibrx Biosciences (NASDAQ: INBX), has released positive primary results from the registrational clinical study ChonDRAgon (n=206). The study...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06628","INBX","BK4139"],"gpt_icon":0},{"id":"2579310166","title":"Transcenta Reports Positive Phase 2 Results for Ozekibart in Chondrosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2579310166","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579310166?lang=en_us&edition=fundamental","pubTime":"2025-10-31 06:44","pubTimestamp":1761864283,"startTime":"0","endTime":"0","summary":"Transcenta Holding Limited has announced that its partner, Inhibrx Biosciences, Inc., has reported positive topline results from the registrational ChonDRAgon Phase 2 study of ozekibart  in patients with advanced or metastatic, unresectable chondrosarcoma. The study, which included 206 patients, investigated ozekibart as a single agent versus placebo. Based on these results, Inhibrx plans to submit a Biologics License Application  in 2026. Ozekibart is a precision-engineered, tetravalent death receptor 5  agonist antibody, with Fast Track and orphan drug designations from the U.S. FDA for chondrosarcoma. Inhibrx is also evaluating ozekibart in combination with irinotecan-based regimens in Ewing sarcoma and colorectal cancer, with early signals supporting further exploration in these tumor types.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL9hyr32:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","INBX","06628","BK4139"],"gpt_icon":0},{"id":"2578629581","title":"Inhibrx’s Phase 1 Study of INBRX-109: A Potential Game-Changer in Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578629581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578629581?lang=en_us&edition=fundamental","pubTime":"2025-10-28 00:53","pubTimestamp":1761583996,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences, Inc. (($INBX)) announced an update on their ongoing clinical study. Inhibrx Biosciences, Inc. is conducting a Phase 1 study ti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inhibrxs-phase-1-study-of-inbrx-109-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inhibrxs-phase-1-study-of-inbrx-109-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","INBX"],"gpt_icon":0},{"id":"2578691400","title":"US Stocks Jump To Records Amid Weak Inflation: Investor Fear Eases, Greed Index Remains In 'Fear' Zone","url":"https://stock-news.laohu8.com/highlight/detail?id=2578691400","media":"Benzinga_recent_news","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578691400?lang=en_us&edition=fundamental","pubTime":"2025-10-27 14:18","pubTimestamp":1761545880,"startTime":"0","endTime":"0","summary":"Stocks hit all-time highs as inflation eased, boosting confidence for Fed rate cut. Fear & Greed Index shows fear, but higher stock prices.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/27/Fear-and-Greed.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/27/Fear-and-Greed.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/10/48425884/us-stocks-jump-to-records-amid-weak-inflation-investor-fear-eases-greed-index-remains-in-fear-zone","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/10/48425884/us-stocks-jump-to-records-amid-weak-inflation-investor-fear-eases-greed-index-remains-in-fear-zone","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU2106854487.HKD","LU2362541513.USD","LU1430594728.SGD","LU1939255532.USD","LU2362541273.HKD","LU1892829315.USD","USJW.SI","BK4533","LU0788109121.HKD","LU0175139822.USD","TSYW.SI","LU1923621640.USD","LU0347712357.USD","LU1721428933.USD","INBX","BK4534","IE00BJTD4N35.SGD","MNQmain","WM","BK4006","LU0069063385.USD","LU2041044095.USD","LU0289739343.SGD","BK4555","LU1989772923.USD","LU2211814178.USD","NVIW.SI","LU2362540622.SGD","USAW.SI","NQmain","LU2463526074.USD","PSQ","F","TQQQ",".IXIC","SQQQ","LU1585245621.USD","LU1623119135.USD","LU2023250504.SGD","BK4574","LU2298064838.USD","BK4588","LU0057025933.USD","KDP","LU0868494617.USD","QID","LU2125910336.SGD","QLD","NUE"],"gpt_icon":1},{"id":"2578523242","title":"Nasdaq Net Change Percentage Gainers & Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2578523242","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578523242?lang=en_us&edition=fundamental","pubTime":"2025-10-25 05:38","pubTimestamp":1761341880,"startTime":"0","endTime":"0","summary":"New Era Energy & Digital    NUAI      5.86     1.91     48.35    51,291,198. MidWestOne Fincl Group      MOFG     39.54    11.17     39.37     1,636,938. Burning Rock Biotech ADR     BNR     13.06     2.56     24.33        80,733. Direxion Daily F Bull 2X    FRDU     36.69     7.10     24.00        17,818. WISeKey Intl Hldg ADR       WKEY     10.37     1.84     21.57       830,714. Viomi Technology ADR        VIOT      3.38     0.58     20.71     9,969,934. GrShr 2x Sh COIN Daily      CONI     34.33    -8.38    -19.62     1,275,645. Apollomics Cl A             APLM     23.00    -5.21    -18.48        13,845. Direxion Daily F Bear 1X    FRDD     19.60    -2.65    -11.90        14,032. Falcon's Beyond Global      FBYD     10.60    -1.42    -11.81        34,809. Only includes stocks with a prior day close of $2 a share. or higher and at least 2,000 shares traded today.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSQ","NQmain","QLD","TSYW.SI",".IXIC","INBX","USJW.SI","SQQQ","QID","NVIW.SI","MNQmain","BK4139","USAW.SI","TQQQ"],"gpt_icon":1},{"id":"2578370541","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2578370541","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578370541?lang=en_us&edition=fundamental","pubTime":"2025-10-25 01:42","pubTimestamp":1761327737,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences (INBX) reported late Thursday its registrational study of ozekibart met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progressi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MOFG","BK4139","BK4211","FIX","INBX","LU0054578231.USD","BK4129","LU0963586101.USD","LU0053671581.USD","BK4567"],"gpt_icon":0},{"id":"2578496549","title":"Stocks Soar To Records After Weak Inflation, Ford Jumps 10%: What's Moving Markets Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2578496549","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578496549?lang=en_us&edition=fundamental","pubTime":"2025-10-25 01:22","pubTimestamp":1761326520,"startTime":"0","endTime":"0","summary":"Wall Street surged to fresh all-time highs Friday as a softer-than-expected inflation reading strengthened market conviction that the Federal Reserve will cut interest rates by 25 basis points at its Oct. 30 policy meeting.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/24/wall-street-bull-midjourney.png?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/24/wall-street-bull-midjourney.png?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/market-summary/25/10/48412547/markets-friday-wall-street-today-record-highs-cpi-inflation-ford-shares","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"262507826bcf4acfc7668f2d04e64506","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/10/48412547/markets-friday-wall-street-today-record-highs-cpi-inflation-ford-shares","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["WTI","F","BK4574","BK4555","BK4588","BK4139","BK4213","INBX","BK4516","BTC.USD.HKCC","BK4099","BK4585"],"gpt_icon":0},{"id":"2577644510","title":"Ford, Inhibrx Biosciences, Comfort Systems, Western Union And Other Big Stocks Moving Higher On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2577644510","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577644510?lang=en_us&edition=fundamental","pubTime":"2025-10-24 22:33","pubTimestamp":1761316380,"startTime":"0","endTime":"0","summary":"U.S. stocks were higher, with the Dow Jones index gaining around 350 points on Friday.Shares of Ford Motor Company  rose sharply during Friday's session after the company reported third-quarter adjusted EPS and sales above estimates.Ford Motor reported quarterly earnings of 45 cents per share, which beat the analyst estimate of 36 cents. Quarterly revenue came in at $47.18 billion, which beat the Street estimate of $43.07 billion and was up from revenue of $43.06 billion from the same period last year.Ford shares surged 9.4% to $13.50 on Friday.Here are some other big stocks recording gains in today’s session.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/24/Ford-Offers-Subprime-Loans.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/24/Ford-Offers-Subprime-Loans.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/25/10/48406724/ford-inhibrx-biosciences-comfort-systems-western-union-and-other-big-stocks-moving-higher-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"262507826bcf4acfc7668f2d04e64506","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/10/48406724/ford-inhibrx-biosciences-comfort-systems-western-union-and-other-big-stocks-moving-higher-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4516","BK4574","BK4106","BK4227","BK4099","BK4585","BK4588","WU","BK4139","INBX","F","BK4555"],"gpt_icon":0},{"id":"2577567487","title":"Why Are Inhibrx Biosciences Shares Soaring 76% After Hours?","url":"https://stock-news.laohu8.com/highlight/detail?id=2577567487","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577567487?lang=en_us&edition=fundamental","pubTime":"2025-10-24 15:05","pubTimestamp":1761289500,"startTime":"0","endTime":"0","summary":"Inhibrx Biosciences shares surged nearly 76% in after-hours trading Thursday after the company reported positive Phase 2 trial results for its cancer drug Ozekibart.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/24/Stock-Market-Growth-Vector-With-Green-Ca.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/24/Stock-Market-Growth-Vector-With-Green-Ca.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/25/10/48398137/why-are-inhibrx-biosciences-shares-soaring-76-after-hours","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/10/48398137/why-are-inhibrx-biosciences-shares-soaring-76-after-hours","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["INBX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}